T. Rowe Price Associates, Inc. 13D and 13G filings for IDEAYA Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 1:22 pm Purchase | 2024-09-30 | 13G | IDEAYA Biosciences, Inc. IDYA | T. Rowe Price Associates, Inc. | 4,015,298 4.800% | 446,360 (+12.51%) | Filing |
| 2024-02-14 10:03 am Purchase | 2023-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA | T. Rowe Price Associates, Inc. | 3,568,938 5.500% | 1,905,410 (+114.54%) | Filing |
| 2023-02-14 12:38 pm Sale | 2022-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA | T. Rowe Price Associates, Inc. | 1,663,528 3.500% | -1,037,997 (-38.42%) | Filing |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | IDEAYA Biosciences, Inc. IDYA | T. Rowe Price Associates, Inc. | 2,701,525 7.000% | 2,701,525 (New Position) | Filing |